Literature DB >> 24517962

Myogenic tumors in nevoid Basal cell carcinoma syndrome.

Simone Hettmer1, Lisa A Teot, Harry Kozakewich, Annette M Werger, Kimberly J Davies, Christopher D M Fletcher, Holcombe E Grier, Carlos Rodriguez-Galindo, Amy J Wagers.   

Abstract

In mice, activated Hedgehog (Hh) signaling induces tumors with myogenic differentiation. In humans, hyperactive Hh signaling due to germline PATCHED1 (PTCH1) mutations has been linked to nevoid basal cell carcinoma syndrome (NBCCS). We report an embryonal rhabdomyosarcoma in a 16-month-old girl with NBCCS and review the literature on myogenic neoplasms in NBCCS, including 8 fetal rhabdomyomas and 3 rhabdomyosarcomas. Of note, 3 population studies, including 255 individuals with NBCCS aged 4 months to 87 years, did not identify any myogenic tumors. Thus, myogenic tumors in NBCCS are rare and include both rhabdomyosarcomas and fetal rhabdomyomas.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24517962      PMCID: PMC4127382          DOI: 10.1097/MPH.0000000000000115

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  21 in total

1.  Nasopharyngeal rhabdomyosarcoma and multiple lentigines syndrome: a case report.

Authors:  D Heney; L Lockwood; E B Allibone; C C Bailey
Journal:  Med Pediatr Oncol       Date:  1992

Review 2.  Mediastinal fetal rhabdomyoma in nevoid basal cell carcinoma syndrome: a case report and review of the literature.

Authors:  Shaomin Yang; Chuan Zhao; Yan Zhang; Songlin Liao
Journal:  Virchows Arch       Date:  2011-06-28       Impact factor: 4.064

3.  A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway.

Authors:  Junhao Mao; Keith L Ligon; Elena Y Rakhlin; Sarah P Thayer; Roderick T Bronson; David Rowitch; Andrew P McMahon
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

4.  Fetal rhabdomyoma. An analysis of nine cases.

Authors:  L P Dehner; F M Enzinger; R L Font
Journal:  Cancer       Date:  1972-07       Impact factor: 6.860

5.  Neural variant of fetal rhabdomyoma and naevoid basal cell carcinoma syndrome.

Authors:  D Hardisson; J A Jimenez-Heffernan; M Nistal; M L Picazo; J A Tovar; F Contreras
Journal:  Histopathology       Date:  1996-09       Impact factor: 5.087

6.  Nevoid basal cell carcinoma syndrome and fetal rhabdomyoma: a case study.

Authors:  Joseph Watson; Kalpana Depasquale; Mahmoud Ghaderi; Seth Zwillenberg
Journal:  Ear Nose Throat J       Date:  2004-10       Impact factor: 1.697

7.  Complications of the naevoid basal cell carcinoma syndrome: results of a population based study.

Authors:  D G Evans; E J Ladusans; S Rimmer; L D Burnell; N Thakker; P A Farndon
Journal:  J Med Genet       Date:  1993-06       Impact factor: 6.318

Review 8.  Nevoid basal cell carcinoma syndrome (Gorlin syndrome).

Authors:  Lorenzo Lo Muzio
Journal:  Orphanet J Rare Dis       Date:  2008-11-25       Impact factor: 4.123

9.  Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma.

Authors:  Patrick S Tarpey; Sam Behjati; Susanna L Cooke; Peter Van Loo; David C Wedge; Nischalan Pillay; John Marshall; Sarah O'Meara; Helen Davies; Serena Nik-Zainal; David Beare; Adam Butler; John Gamble; Claire Hardy; Jonathon Hinton; Ming Ming Jia; Alagu Jayakumar; David Jones; Calli Latimer; Mark Maddison; Sancha Martin; Stuart McLaren; Andrew Menzies; Laura Mudie; Keiran Raine; Jon W Teague; Jose M C Tubio; Dina Halai; Roberto Tirabosco; Fernanda Amary; Peter J Campbell; Michael R Stratton; Adrienne M Flanagan; P Andrew Futreal
Journal:  Nat Genet       Date:  2013-06-16       Impact factor: 38.330

10.  Mutations in Hedgehog pathway genes in fetal rhabdomyomas.

Authors:  Simone Hettmer; Lisa A Teot; Paul van Hummelen; Laura MacConaill; Roderick T Bronson; Claudia Dall'Osso; Junhao Mao; Andrew P McMahon; Peter J Gruber; Holcombe E Grier; Carlos Rodriguez-Galindo; Christopher D Fletcher; Amy J Wagers
Journal:  J Pathol       Date:  2013-09       Impact factor: 7.996

View more
  8 in total

Review 1.  Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome.

Authors:  William D Foulkes; Junne Kamihara; D Gareth R Evans; Laurence Brugières; Franck Bourdeaut; Jan J Molenaar; Michael F Walsh; Garrett M Brodeur; Lisa Diller
Journal:  Clin Cancer Res       Date:  2017-06-15       Impact factor: 12.531

Review 2.  The current landscape of rhabdomyosarcomas: an update.

Authors:  Julia Leiner; François Le Loarer
Journal:  Virchows Arch       Date:  2019-11-06       Impact factor: 4.064

3.  Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group.

Authors:  Lisa A Teot; Michaela Schneider; Aaron R Thorner; Jing Tian; Yueh-Yun Chi; Matthew Ducar; Ling Lin; Marcin Wlodarski; Holcombe E Grier; Christopher D M Fletcher; Paul van Hummelen; Stephen X Skapek; Douglas S Hawkins; Amy J Wagers; Carlos Rodriguez-Galindo; Simone Hettmer
Journal:  Cancer       Date:  2018-02-20       Impact factor: 6.860

4.  Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia.

Authors:  Melissa A Burns; Zi Wei Liao; Natsuko Yamagata; Gayle P Pouliot; Kristen E Stevenson; Donna S Neuberg; Aaron R Thorner; Matthew Ducar; Emily A Silverman; Stephen P Hunger; Mignon L Loh; Stuart S Winter; Kimberly P Dunsmore; Brent Wood; Meenakshi Devidas; Marian H Harris; Lewis B Silverman; Stephen E Sallan; Alejandro Gutierrez
Journal:  Leukemia       Date:  2018-03-20       Impact factor: 11.528

5.  Different Response of Ptch Mutant and Ptch Wildtype Rhabdomyosarcoma Toward SMO and PI3K Inhibitors.

Authors:  Natalie Geyer; Rosalie Ridzewski; Julia Bauer; Maria Kuzyakova; Kai Dittmann; Christian Dullin; Albert Rosenberger; Hans-Ulrich Schildhaus; Anja Uhmann; Simone Fulda; Heidi Hahn
Journal:  Front Oncol       Date:  2018-09-25       Impact factor: 6.244

6.  Molecular-Clinical Correlation in Pediatric Medulloblastoma: A Cohort Series Study of 52 Cases in Taiwan.

Authors:  Kuo-Sheng Wu; Donald Ming-Tak Ho; Shiann-Tarng Jou; Alice L Yu; Huy Minh Tran; Muh-Lii Liang; Hsin-Hung Chen; Yi-Yen Lee; Yi-Wei Chen; Shih-Chieh Lin; Feng-Chi Chang; Min-Lan Tsai; Yen-Lin Liu; Hsin-Lun Lee; Kevin Li-Chun Hsieh; Wen-Chang Huang; Shian-Ying Sung; Che-Chang Chang; Chun Austin Changou; Kung-Hao Liang; Tsung-Han Hsieh; Yun-Ru Liu; Meng-En Chao; Wan Chen; Shing-Shung Chu; Er-Chieh Cho; Tai-Tong Wong
Journal:  Cancers (Basel)       Date:  2020-03-11       Impact factor: 6.639

Review 7.  Genetic Predisposition to Solid Pediatric Cancers.

Authors:  Mario Capasso; Annalaura Montella; Matilde Tirelli; Teresa Maiorino; Sueva Cantalupo; Achille Iolascon
Journal:  Front Oncol       Date:  2020-10-28       Impact factor: 6.244

8.  Context-dependent modulation of aggressiveness of pediatric tumors by individual oncogenic RAS isoforms.

Authors:  Julia Bauer; Nicole Cuvelier; Nada Ragab; Katja Simon-Keller; Frauke Nitzki; Natalie Geyer; Dominik S Botermann; Dominik P Elmer; Albert Rosenberger; Thomas A Rando; Stefano Biressi; James A Fagin; Dieter Saur; Christian Dullin; Hans-Ulrich Schildhaus; Walter Schulz-Schaeffer; Fritz Aberger; Anja Uhmann; Heidi Hahn
Journal:  Oncogene       Date:  2021-06-25       Impact factor: 9.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.